Chairman
Sue Siegel — Mohr Davidow Ventures (MDV)
Ms. Siegel leads investments in companies focused on personalized medicine, enabling platform technologies for biomedical research, and innovative healthcare businesses with disruptive business models. Prior to joining MDV, she was President and Director of Affymetrix, Inc., a company that pioneered GeneChip® technology, which helped accelerate the advent of personalized medicine in modern medicine. Ms. Siegel serves on the Board of Directors of Pacific Biosciences, Navigenics, Corventis, RainDance Technologies and On-Q-ity. She serves on the Presidents' Circle of the National Academies, is an advisor to the Institute of Medicine, chairs the External Relations Committee of The Gladstone Institutes, and is a Henry Crown Fellow of the Aspen Institute. For more on Ms. Siegel, please click here.
Brook Byers — Kleiner Perkins Caufield & Byers (KPCB)
Mr. Byers has been a venture capital investor since 1972. He has been closely involved with more than 50 new technology-based ventures, over half of which have already become public companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 110 life sciences companies which have developed hundreds of products to treat major underserved medical needs for millions of patients. Mr. Byers is currently on the Board of Directors of 10 companies, most recently joining CardioDX, Genomic Health, Five Prime Therapeutics, OptiMedica®,
Pacific Biosciences, Tethys and XDx. For more on Mr. Byers, please
click here.
William Hagstrom — Chief Executive Officer, Crescendo Bioscience
Mr. Hagstrom has over 25 years of leadership experience in the healthcare industry. Prior to joining Crescendo Bioscience, he was President of Alpha BioPartners, a strategic consulting firm for early-stage biotechnology companies. While at Alpha BioPartners, Mr. Hagstrom co-founded Altheus Therapeutics and Biolytx Pharmaceuticals. Previously, he served as President and CEO of UroCor, a specialty diagnostic services company focused on urological cancers, which he built from start-up through market launch, product expansion and penetration of over 35% of the U.S. urology market. Mr. Hagstrom has also held a variety of management positions in large, multinational healthcare companies including Becton, Dickinson and Company, American Hospital Supply and Baxter International.
Lawrence B. Leisure — Managing Director, Ingenix Consulting
Mr. Leisure is a Managing Director at Ingenix Consulting where he leads their Payer & Employer segment. He has had an extensive career in healthcare, serving in a number of senior consulting and industry roles. Most recently he held the role of President of iMetrikus, a leader in the broad application of biometric monitoring to population health. From 2004 to 2007, he served as a senior executive at Kaiser Foundation Health Plan, where he was engaged in shaping their go-to-market strategy and in building a high-performance sales and account management organization. Until 2004, Mr. Leisure was the Global Managing Partner, Healthcare Industry at Accenture. He began his consulting career at Towers Perrin where he rose from consultant to the National Practice Leader for its Group Benefits and Managed Care Practice.
Jack L. Oliver III — Senior Advisor, Barclays and Senior Advisor, Bryan Cave LLP
Mr. Oliver is a Senior Advisor to Barclays, providing senior relationship management for top clients across investment banking, capital markets, and private wealth management. Additionally, he is a Senior Advisor of Bryan Cave LLP, an international law firm. Mr. Oliver served as National Finance Vice-Chairman for Bush-Cheney 04 and Victory 2004, managing the campaign's $240 million national finance plan. Prior to that, Mr. Oliver was Deputy Chairman of the Republican National Committee. Mr. Oliver also works closely with the non-profit sector, having served for two years as Co-Chairman of the ONE Campaign, an organization to raise public awareness about global poverty and disease in developing countries, among other initiatives. In addition to Crescendo, Mr. Oliver is on the Board of Directors for E-Health Corporation and Innovus, Inc.
For more on Mr. Oliver, please click here.